Helsana HealthInvest

Yazen is a digital healthcare provider focused on offering customized weight loss programs primarily for middle-aged men dealing with obesity and related health issues, including potential testosterone deficiencies. The platform connects users with a multidisciplinary team of professionals, such as doctors, psychologists, dietitians, and personal trainers, to develop personalized weight management plans. By analyzing individual data, Yazen provides recommendations for lifestyle changes and, when necessary, medication to enhance both physical and mental well-being.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.

Kenbi is a nurse-centric outpatient care company focused on enhancing healthcare delivery by supporting nurses and addressing gaps in the system. It offers outpatient care management services that leverage technology and a collegial organizational structure to organize local care teams. These teams provide at-home services, which may include medical care covered by insurance, household assistance, advice, and companionship. By streamlining operations and reducing bureaucratic burdens, Kenbi enables healthcare practitioners to devote more time to patient care, thus improving the overall experience for patients and their families.

Entyre GmbH, founded in 2017 and based in Hamburg, Germany, operates an online platform that assists patients and caregivers in navigating bureaucratic processes within the healthcare system. The company utilizes proprietary data and algorithms to enhance decision-making for patients, doctors, and insurance companies by providing technical solutions that identify and rectify incorrect supplies. By evaluating outpatient care, Entyre enables users to better manage their healthcare needs and address the challenges posed by demographic changes. The company also offers contact information, including email, telephone numbers, and physical addresses, on its website to facilitate inquiries.

epha.health is a clinical decision support service for physicians and pharmacists. The service uses AI and algorithms to predict the risk and exposure in polypharmacy and computes possible drug alternatives based on patient factors.